International Centre For Diarrhoeal Disease Research, Bangladesh
Clinical trials sponsored by International Centre For Diarrhoeal Disease Research, Bangladesh, explained in plain language.
-
Old drug, new hope? ivermectin shows promise for PKDL in small trial
Disease control CompletedThis early study tested whether a common anti-parasite drug, ivermectin, could safely treat PKDL, a skin condition that can develop after kala-azar. Thirty adults in Bangladesh received either ivermectin or the standard treatment miltefosine. The goal was to see if ivermectin cou…
Phase: EARLY_PHASE1 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
Old drug, new hope? ivermectin shows promise for PKDL in small study
Disease control CompletedThis early study tested the safety and effectiveness of the drug ivermectin for treating post-kala-azar dermal leishmaniasis (PKDL), a skin condition that can develop after recovery from visceral leishmaniasis. Ten otherwise healthy adults with PKDL took ivermectin pills for five…
Phase: EARLY_PHASE1 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Did early cash and parenting help kids' brains? study checks years later.
Knowledge-focused CompletedThis study followed 599 mother-child pairs in Bangladesh to see if early parenting support and cash transfers (given when children were babies) improved kids' IQ, learning, and home environment at ages 6-9. Researchers measured intelligence, reading, math, and maternal well-being…
Phase: NA • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Knowledge-focused
Last updated May 17, 2026 11:36 UTC